IRIDEX CORP
For the period ended Mar 29, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2025 · Filed May 13, 2025
IRIX$0.70-0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows
(Unaudited, in thousands)
| Three Months Ended | ||
|---|---|---|
| March 29, 2025 | March 30, 2024 | |
| Operating activities: | ||
| Net loss | $(1,686) | $(3,464) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Loss on extinguishment of convertible note payable | 1,335 | — |
| Depreciation and amortization | 135 | 173 |
| Amortization of operating lease right-of-use assets | 246 | 230 |
| Accretion of original issue discount | 58 | — |
| Amortization of debt issuance costs | 78 | — |
| Stock-based compensation | 213 | 394 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (729) | 202 |
| Receivable from related party | (263) | 306 |
| Inventories | 675 | (1,097) |
| Prepaid expenses and other current assets | (393) | (1,154) |
| Other long-term assets | 96 | 72 |
| Accounts payable | (1,291) | 3,182 |
| Payable to related party | 51 | 82 |
| Accrued compensation | 343 | 637 |
| Accrued expenses | 492 | (884) |
| Deferred revenue | (468) | (274) |
| Operating lease liabilities | (250) | (225) |
| Other liabilities | 209 | 172 |
| Net cash used in operating activities | (1,149) | (1,648) |
| Investing activities: | ||
| Acquisition of property and equipment | (11) | (3) |
| Net cash used in investing activities | (11) | (3) |
| Financing activities: | ||
| Proceeds from issuance of convertible note payable | 4,000 | — |
| Payments on note payable | (3,961) | — |
| Proceeds from issuance of Series B preferred stock | 6,000 | — |
| Net cash provided by financing activities | 6,039 | — |
| Effect of foreign exchange rate changes | (22) | 36 |
| Net increase (decrease) in cash and cash equivalents | 4,857 | (1,615) |
| Cash and cash equivalents, beginning of year | 2,387 | 7,034 |
| Cash and cash equivalents, end of year | $7,244 | $5,419 |
| Supplemental disclosure of cash flow activities: | ||
| Cash paid during the period for income taxes | $24 | $— |
| Supplemental disclosure of non-cash activities: | ||
| Debt issuance cost | $360 | $— |
| Issuance of common shares in conjunction with extinguishment of convertible notes payable | $250 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.